TG Therapeutics
TGTX
TGTX
91 hedge funds and large institutions have $178M invested in TG Therapeutics in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
29% less capital invested
Capital invested by funds: $250M → $178M (-$71.2M)
88% less call options, than puts
Call options by funds: $115K | Put options by funds: $962K
Holders
91
Holding in Top 10
1
Calls
$115K
Puts
$962K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$8.07M | |
| 3 | +$1.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$925K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$924K |
Top Sellers
| 1 | -$13M | |
| 2 | -$7.06M | |
| 3 | -$4.47M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.37M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.46M |